14-day Premium Trial Subscription Sign Up For FreeGet Free

No Pain, No Gain.Week 21 On Stock Market Click to watch.

ARCA biopharma Stock Forecast

NASDAQ:ABIO BUY SELL

$2.32 (0%)

Volume: 66.413k

Closed: May 23, 2022

Hollow Logo Score: -4.032

ARCA biopharma Stock Forecast

BUY SELL NASDAQ:ABIO
$2.32 (0%)

Volume: 66.413k

Closed: May 23, 2022

Score Hollow Logo -4.032

ABIO Stock Trend

The stock lies in the lower part of a wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $2.24 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift.

Given the current short-term trend, the stock is expected to rise 10.3% during the next 3 months and, with a 90% probability hold a price between $2.47 and $2.95 at the end of this 3-month period.

Data

Date Bottom Mid Top
2022-05-25 $2.24 $2.46 $2.68
2022-05-26 $2.25 $2.46 $2.68
2022-05-27 $2.25 $2.47 $2.69
2022-05-31 $2.25 $2.47 $2.69
2022-06-01 $2.26 $2.48 $2.69
2022-06-02 $2.26 $2.48 $2.70
2022-06-03 $2.27 $2.48 $2.70
2022-06-06 $2.27 $2.49 $2.71
2022-06-07 $2.27 $2.49 $2.71
2022-06-08 $2.28 $2.50 $2.72
2022-06-09 $2.28 $2.50 $2.72
2022-06-10 $2.29 $2.50 $2.72
2022-06-13 $2.29 $2.51 $2.73
2022-06-14 $2.29 $2.51 $2.73
2022-06-15 $2.30 $2.52 $2.74
2022-06-16 $2.30 $2.52 $2.74
2022-06-17 $2.31 $2.53 $2.74
2022-06-21 $2.31 $2.53 $2.75
2022-06-22 $2.32 $2.53 $2.75
2022-06-23 $2.32 $2.54 $2.76
2022-06-24 $2.32 $2.54 $2.76
2022-06-27 $2.33 $2.55 $2.76
2022-06-28 $2.33 $2.55 $2.77
2022-06-29 $2.34 $2.55 $2.77
2022-06-30 $2.34 $2.56 $2.78
2022-07-01 $2.34 $2.56 $2.78
2022-07-05 $2.35 $2.57 $2.78
2022-07-06 $2.35 $2.57 $2.79
2022-07-07 $2.36 $2.57 $2.79
2022-07-08 $2.36 $2.58 $2.80

About ARCA biopharma

ARCA biopharma ARCA biopharma, Inc., a biopharmaceutical company, focuses on developing genetically-targeted therapies for cardiovascular diseases. Its lead product candidate is Gencaro, a pharmacologically beta-blocker and mild vasodilator, which is in clinical trial for the treatment of atrial fibrillation in patients with heart failure and left ventricular with reduced left ventricular ejection fraction. The company also engages in developing recombinant Nem... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!
.

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT